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Abstract The expression of GLI1 as a downstream gene of
sonic hedgehog (Hh) pathway, studied in a variety of cancers
including esophageal squamous cell carcinoma (ESCC).
However, the interaction of Hh with other developmental
pathways needs to be elucidated. In this study, we aimed to
investigate the correlation of GLI1 expression with transcrip-
tion factors (TFs) of stem cell signaling pathways, and their
association with clinico-pathological data of ESCC. Using
real-time PCR, we assessed the expression of GLI1 mRNA
in 49 ESCC patients, and analyzed the correlation between
GLI1 and selected TFs. The results showed overexpression
of GLI1 in ESCC tissues in significant correlation with lymph
node metastasis. The GLI1 up-regulation was also correlated
to the SOX2 and SIZN1 (Smad-interacting zinc finger
protein) expression. These correlations may confirmed the
role of GLI1 in crosstalk among different cell signaling path-
ways in ESCC. To our knowledge, this is the first study to
demonstrate the correlation of GLI1 expression with stemness
marker and BMP signaling in ESCC.
Keywords GLI1 overexpression . Stemness . SIZN1 .
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Introduction
Esophageal cancer (EC) is the sixth cause of mortality in the
world. The most prevalence type of EC in Asian countries is
esophageal squamous cell carcinoma (ESCC) (Zhang 2013).
Since the diagnosis of the disease is usually performed at ad-
vanced stages of the malignancy, the 5-year survival rate after
surgery is approximately 35%. Therefore, it seems necessary to
recruit the molecular mechanisms of cancer progression in pre-
vention, diagnosis, and therapeutic interventions of cancers
(Forghanifard et al. 2014a). The molecular investigation are
carrying out in different aspects of cellular mechanisms to help
understanding the system biology of ESCC (Dadkhah et al.
2013; Moghbeli et al. 2016a, b).
Hedgehog (Hh) signaling is normally involved in develop-
ment, differentiation of embryonic tissues, and hemostasis of
normal adult cells, as well as carcinogenesis (Rimkus et al.
2016). Canonical Hh signaling initiates by binding of the Hh
ligands, most likely by Sonic HH (SHH), to its receptor called
patched (Ptch). Smoothened (Smo), a potential G protein-
coupled receptor (GPCR), is subsequently alleviated from Ptch,
which mediates Smo repression. Smo signal transduction finally
leads to increased expression and activation of Glioma-
associated oncogene homolog 1 (Gli-1) (Ingham 2008).
Mutations in different transcription factor of Hh signaling as well
as deregulation of its target genes give rise to a variety of disor-
ders such as Gorline syndrome and basal cell carcinoma
(Evangelista et al. 2006). On the other hand, growing evidences
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elucidated the non-canonical regulation of GLI1, SMO-indepen-
dent, which ismodulated by diverse signaling cascades including
TGFẞ, NOTCH, SMAD and RAS (Aberger et al. 2012).
GLI1, as a downstream gene of Hh canonical signaling,
culminate to control the TFs of Hh pathway target genes. It
activates Cyclin D2 and FOXM1 in basal cell carcinoma, and
also has oncogenic role in different malignancies including
ESCC (Yoshikawa et al. 2008; Wei and Xu 2011; Min et al.
2013; Mori et al. 2007), papillary thyroid (Bian et al. 2014; Lee
et al. 2015), hepatocellular, and head and neck squamous cell
carcinomas (Dimitrova et al. 2013; Gai et al. 2014), as well as
breast (Xu et al. 2010), ovarian (Ke et al. 2015), and cervical
cancers (Nayak et al. 2016). The correlation of GLI1 with
PI3K/AKT – MAPK and WNT signaling pathways, has role
in proliferation of ESCC and colon cancer, respectively (Wei
and Xu 2011; Varnat et al. 2010) . SHH is correlated to the
NOTCH pathway in medulloblastoma cancer stem cell (CSC)
populations through regulation of GLI1 expression with HES1
(Cordeiro et al. 2014; Schreck et al. 2010). The overexpression
of GLI1 was linked to lymph node metastasis and EMT of
ESCC patients (Min et al. 2013; Mori et al. 2007).
Nevertheless, the correlation of GLI1 expression with stemness
state of ESCC and EMT induction is not clear yet. Therefore,
we aimed to analyze the expression of GLI1 in ESCC patients
and elucidate its correlation with TFs of stemness state, as well
as their association with demographic data of ESCC patients.
Material and methods
The 49 ESCC with related margin normal tissues were collected
form patients who referred toOncologyOmidHospital,Mashhad,
Iran. All patients did not receive preoperative chemo- and radio-
therapy experiences before surgery. The pathological featureswere
categorized based on the seventh edition of Union International
Cancer TNM classification guidelines (Sobin et al. 2011). The
study were approved by the MUMS ethics committee and all
patients declared their informed consent.
RNA isolation and qRT-PCR
RNA was extracted from tissues using TriPure RNA extrac-
tion reagent (Roche, Nutley, NJ). The cDNA synthesis was
performed by PrimeScript First Strand cDNA Synthesis Kit
(Takara, japan). The cDNA was amplified by SYBR green
method and specific primer sets (Table 1) in Stratagene Mx-
3000P real-time thermocycler (Stratagene, La Jolla, CA) to
compare gene expression. ROX was used as reference dye.
The following optimal thermal condition was used:
10 min at 95 0C, 39 cycles of 15 s at 95 0C, 20 s at 56
0C, and 45 s at 72 0C. All experiments were performed in
triplicate. Glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) was used as normalizer. The PCR efficiency
for the genes was measured using standard curves and
the equation E = 2 (−ΔΔCT) was used to measure fold
change of genes expression (Raeisossadati et al. 2011;
Khales et al. 2015). Based on this equation, more than 2
fold change of mRNA expression in tumors in compari-
son with related normal tissues was introduced as overex-
pression, while less than −2 fold change was considered
as underexpression. The range between 2 and −2 was
described as no change or normal expression.
Statistical analysis
Using SPSS 23 statistical package (SPSS, Chicago, IL), the
data were analyzed. The χ2 or Fisher exact test, independent-
sample t test and ANOVAwere used to evaluate the correla-
tion of gene expression with clinicopathological data. The
Pearson’s test was used to correlate between GLI1 and other
genes expression. P < 0.05 was considered statistically
significant.
Results
Study population
23 males and 26 females were recruited in this study. The
mean age ± standard deviation (SD) of patients was
61.40 ± 12.10. The range of tumor size in samples was 1.50
to 12.00 (Mean ± SD: 4.17 ± 1.90) which resected from lower,
middle or upper parts of esophagus. The tumoral characteris-
tics of tissues were histologically confirmed by pathologist.
The clinicopathological features of the patients are presented
in Table 2.
Table 1 Primer sequences used
for qRT-PCR Gene Forward Primer Reverse primer Product
size
GAPDH GGAAGGTGAAGGTCGGAGTCA GTCATTGATGGCAACAATAT
CCACT
101 bp
GLI1 AGGGAGGAAAGCAGACTGAC CCAGTCATTTCCACACCACT 137 bp
SZIN1 GCCAGGAAGCGAAAACACAC
AATC
GCCACTCTTGACCTCTCCATCTC 161 bp
SOX2 AGCTACAGCATGATGCAGGA GGTCATGGAGTTGTACTGCA 126 bp
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Increased expression level of GLI1 in ESCC
Using real-time PCR, Overexpression of GLI1 was detected
in ESCC. The mean (±SD) of gene expression in ESCC tis-
sues was 0.99 (± 1.86). The lower and upper fold changes of
gene expression were −4.80 and 6.43, respectively. GLI1 was
significantly overexpressed in 14 out of 49 patients (28.6%, p
value <0.05).
Correlation of GLI1 gene expression
and clinicopathological features of ESCC patients
The correlation between GLI1 mRNA expression and differ-
ent clinicopathological characteristics of ESCC patients was
analyzed. The GLI1 overexpression was correlated with age
(p = 0.02). According to the results, 88.2% of studied popu-
lation were over 40 years old. GLI1 overexpression was asso-
ciated with the increased range of age. There was also corre-
lation between increased level of GLI1 expression and loca-
tion of tumor (p = 0.002). 51% (25 out of 49) of ESCCs were
resected from the middle part of esophagus which 40% (10
out of 25) of these tissues showed GLI1 overexpression.
Furthermore, a significant correlation between GLI1 overex-
pression and lymph node metastasis was observed (p < 0.05).
22 of 49 patients (44.9%) had lymph node metastasis which
GLI1 was overexpressed in 36% (8 out of 22) of these sam-
ples. Although GLI1 gene expression was not significantly
correlated to the surgical stage of the disease, the majority of
GLI1 overexpressed samples (9 of 14) were categorized into
primary surgical stages (stages 1 and 2), while the others (5 of
14) showed advanced stages (surgical stages 3 and 4).
Correlation of GLI1 with SOX2 and SIZN1 in ESCC
The Pearson correlation and regressionmodel indicated the signif-
icant correlation of GLI1 with SOX2 and SIZN1 in ESCC. The
results showed significant correlation between GLI1 and SOX2
(P = 0.011, correlation coefficient: 0.360) and SIZN1 (p = 0.010,
correlation coefficient: 0.363) in ESCC (Tables 3 and 4). It means
that in tumor sample with GLI1 overexpression the level of SOX2
Table 2 Correlation of GLI1
mRNA expression with
clinicopathological features of
ESCC patients
Feature GLI1 expression P value
Unchanged/Under
(n)
Over
(n)
Sex Male 20 3 0.035*
Female 15 11
Lymph node metastasis No metastasis 21 6
Node metastasis 14 8 0.047*
Depth of tumor invasion T1,2 7 4 0.511
T3,4 28 10
Surgical stage Stage1,2 21 9 0.520
Stage3,4 14 5
Grade of differentiation P. D 3 2 0.460
M. D 25 8
W. D 7 4
Location Lower 20 2 0.002*
Middle 15 10
Upper 0 2
*Significant
Table 3 Correlation between
GLI1 and SOX2 mRNA
expression in ESCC
Pearson correlation SOX2 P value
Unchanged/Underexpression Overexpression
GLI1
Unchanged/ Underexpression 27 8 35
Overexpression 6 8 14 0.011*
Total 33 16 49
*Significant correlation
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and SIZN1 gene expression were also increased (the data of
SIZN1 expression in ESCC is unpublished). In 49 patients,
16.3% had overexpression of both GLI1 and SOX2.
Concomitant overexpression of GLI1 and SIZN1 was detected
in 12.3% of samples. In addition to Pearson correlation, regression
model for GLI1 as dependent and SOX2 as well as SIZN1 as
independent variables illustrated the significant correlation be-
tween GLI1 and the genes (Fig. 1).
Discussion
Stemness state signaling pathways play role in tumorigenesis.
The crosstalk between these pathways is important to understand
cancer system biology, leading to predict new biomarkers and
effective therapeutic targets (Werner et al. 2014; Forghanifard
et al. 2015). It has been shown that EMT and stemness state
pathways are linked together in different aspects (Mani et al.
2008; Morel et al. 2008). It is also indicated that EMT is a
complicated process which conducted with a variety of TFs
(Forghanifard et al. 2012). Since expression of TFs is different
in tumor cells, the interaction among such TFsmay be a cause of
tumor heterogeneity (Sun and Yu 2015). In the present study,
gene expression of GLI1 was assessed in ESCC patients and its
correlation with lymph node metastasis was detected. The in-
creased GLI1 expression was correlated to the SOX2 and
SIZN1 gene expression, which may introduce a new crosstalk
between Hh and stemness state pathways.
A couple of studies have reported correlation of GLI1 expres-
sion with lymph node metastasis and EMT in ESCC (Min et al.
2013; Mori et al. 2007). S Min et al. demonstrated that GLI1
promotes the EMT via SNAIL expression and E-cadherin inhi-
bition (Min et al. 2013). In line with these reports, current study
was also showed the upregulation of GLI1 mRNA in ESCC in
significant correlation with lymph node metastasis, emphasizing
the link between GLI1 expression and downstream associated
Table 4 Correlation between
GLI1 and SIZN1 mRNA
expression in ESCC
Pearson correlation SIZN1 P value
Unchanged/Underexpression Overexpression
GLI1
Unchanged/ Underexpression 30 5 35
Overexpression 8 6 14 0.010*
Total 38 11 49
*Significant correlation
SIZN1
7.505.002.500.00-2.50
8.00
6.00
4.00
2.00
0.00
-2.00
-4.00
GLI1
Linear
Observed
SOX2
10.005.000.00-5.00
8.00
6.00
4.00
2.00
0.00
-2.00
-4.00
GLI1
Linear
Observed
Fig. 1 Correlation between GLI1 and the genes (SOX2 and SIZN1) is depicted as regression plot. The samples with high level of GLI1 expression show
elevated level of SOX2 and SIZN1 expression as well. The X and Y axis show fold change of gene expression
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genes with EMT in ESCC. Our recent reports indicated that
EMT and stem cell markers have main role in progress of
ESCC (Forghanifard et al. 2012, 2016a, b). The results from
gene expression analysis of different stem cell pathways in
ESCC and their correlation with GLI1, statistically predicts cor-
relation of GLI1 and critical TFs including SOX2 and SIZN1
genes.
It has been shown that SOX2 was correlated statistically
with SALL4 and MEIS1, in significant association with
lymph node metastasis of ESCC (Rad et al. 2016;
Forghanifard et al. 2014b). In this study, the increased level
of GLI1 was associated with overexpression of SOX2 in
ESCC which may be resembled similar regulatory process in
non-small cell lung cancer (NSCLC). It was reported that
GLI1 regulates SOX2 expression through its promotor in
NSCLC (Bora-Singhal et al. 2015). Varnat et al. also showed
the Hh signaling regulates the embryonic stem-like signature
components including NANOG, SOX2, OCT4 and KLF4 in
colon cancer, which the level of these TFs increased after
enhanced expression of GLI1 (Varnat et al. 2010).
Furthermore, GLI1 regulates SOX2 through crosstalk of
SHH-BMP signaling pathway in epithelial stem cell mainte-
nance duringmolar development. It has been shown that BMP
signaling cascade affects GLI1 to regulate the SOX2 expres-
sion and control epithelial stem cell fate (Li et al. 2015). In line
with these reports, our study confirmed overexpression of
both genes in poorly differentiated ESCC cases with advanced
surgical stages (stages III and IV). It may suggest that GLI1
through SOX2 activation maintains the cells in poorly differ-
entiated state (Fig. 2).
S IZN1 , z i n c f i n g e r CCHC- t yp e c on t a i n i n g
12 (ZCCHC12), encodes a downstream effector of BMP sig-
naling and modulates this pathway by interacting with SMAD
family members, especially SMAD1, and associates with the
cAMP-responsive element-binding protein (CREB) (Cho
et al. 2008). Although, there is rare literature reviews about
the SIZN1 expression in malignancies, its overexpression was
Fig. 2 Histological pictures of
four ESCC cases with different
stages. I. Awell differentiated
squamous cell carcinoma with
keratin pearl formation and
minimal nuclear atypia. A stage I
tumor with GLI1 overexpression
(H&E stain, ×200). II. The
moderately differentiated tumor
invades muscularis propria with
stage II. GLI1 and SOX2
overexpression was detected in
this sample (H&E stain, ×100).
III. The poorly differentiated
tumor with perineural invasion in
ESCC. A stage III tumor with
GLI1 and SOX2 overexpression
(H&E stain, ×200). IV. The
poorly differentiated squamous
cell carcinoma demonstrates
pleomorphic cells with high
nucleo-cytoplasmic ratio and ele-
vated expression of SOX2. The
patient had distant metastasis
(stage IV) (H&E stain, ×200)
Fig. 3 SIZN1 may involve in EMT induction through GLI1 expression
and BMP signaling. SIZN1 interacts with the receptor-regulated SMADs
(SAMD1/2/3/5/8) to co-activate the signaling and recruit SMAD4. GLI1
expression is enhanced following SMAD4/SMAD3 binding to its regu-
latory region, and subsequently GLI1 induces the SNAIL expression
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studied in papillary thyroid carcinoma (PTC) which was
higher compared to nodular goiter (Li et al. 2012). In present
study overexpression of GLI1 was correlated to the high level
of SIZN1 expression. The association between GLI1 and
SIZN1may propose crosstalk between BMP and Hh signaling
pathways. BMP signaling pathway initiates by transforming
growth factor-β (TGF-β) followed by phosphorylation of
Smad1/2/3/5/8. TGF-β is an inducer of EMT in cancers which
cooperates with other developmental pathways to promote
EMT. It has been shown that Hh components through
TGF-β give rise breast cancer metastasis to bone (Javelaud
et al. 2011). Jingyu et al., reviewed the induction of EMT by
different pathways including TGF-β, SHH, andWNT (Zhang
et al. 2016). It is proposed that TGF-β phosphorylates one of
the receptor-regulated SMADs including Smad1/2/3/5/8,
followed by recruiting of the SAMD4 to upregulate SNAIL.
On the other hand, SMAD3/SMAD4 dimer upregulates the
GLI1 expression. Regarding interaction of SIZN1 with
SMAD family, it can be suggested that correlation of GLI1
with SIZN1 may be happened through TGF-β /EMT process
crosstalk (Fig. 3).
In conclusion, this study predicted the association of in-
creased level of GLI1 with SOX2 and SIZN1, the main TFs
in stemness state and BMP signaling pathways, respectively.
The correlation of GLI1 gene expression with lymph node
metastasis, as well as its association with SOX2 and SIZN1,
may suggest involvement of such cell signaling crosstalk in
EMT promotion, as one of the main features of aggressive
ESCC.
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